Multimodal Transformer Integrating CT and Pathology for Postoperative Risk Stratification in Stage I Non–Small Cell Lung Cancer

= .06). Conclusion The DLRTransformer improved postoperative risk stratification compared with guideline-based risk stratification and identified patients with stage I NSCLC who benefited from adjuvant therapy.